These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 35435735)
1. Cell-Selective Adeno-Associated Virus-Mediated Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735 [TBL] [Abstract][Full Text] [Related]
2. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome. Niibori Y; Lee SJ; Minassian BA; Hampson DR Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809 [TBL] [Abstract][Full Text] [Related]
4. A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. Favero M; Sotuyo NP; Lopez E; Kearney JA; Goldberg EM J Neurosci; 2018 Sep; 38(36):7912-7927. PubMed ID: 30104343 [TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model. Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817 [TBL] [Abstract][Full Text] [Related]
6. Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1a rescues parvalbumin interneuron excitability and reduces seizures in a mouse model of Dravet Syndrome. Wengert ER; Wagley PK; Strohm SM; Reza N; Wenker IC; Gaykema RP; Christiansen A; Liau G; Patel MK Brain Res; 2022 Jan; 1775():147743. PubMed ID: 34843701 [TBL] [Abstract][Full Text] [Related]
7. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development. Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421 [TBL] [Abstract][Full Text] [Related]
8. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome. Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378 [TBL] [Abstract][Full Text] [Related]
9. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome. Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317 [TBL] [Abstract][Full Text] [Related]
11. A novel rat model of Dravet syndrome recapitulates clinical hallmarks. Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice. Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790 [TBL] [Abstract][Full Text] [Related]
13. Synaptic Integration in CA1 Pyramidal Neurons Is Intact despite Deficits in GABAergic Transmission in the Chancey JH; Howard MA eNeuro; 2022; 9(3):. PubMed ID: 35523580 [TBL] [Abstract][Full Text] [Related]
14. Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome. Mattis J; Somarowthu A; Goff KM; Jiang E; Yom J; Sotuyo N; Mcgarry LM; Feng H; Kaneko K; Goldberg EM Elife; 2022 Feb; 11():. PubMed ID: 35212623 [TBL] [Abstract][Full Text] [Related]
15. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq. Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696 [TBL] [Abstract][Full Text] [Related]
16. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome. Cheah CS; Lundstrom BN; Catterall WA; Oakley JC J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705 [TBL] [Abstract][Full Text] [Related]
17. Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). Beretta S; Gritti L; Ponzoni L; Scalmani P; Mantegazza M; Sala M; Verpelli C; Sala C Mol Autism; 2022 Jan; 13(1):1. PubMed ID: 34980259 [TBL] [Abstract][Full Text] [Related]
18. Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function. Di Berardino C; Mainardi M; Brusco S; Benvenuto E; Broccoli V; Colasante G Brain; 2024 Apr; 147(4):1216-1230. PubMed ID: 37812819 [TBL] [Abstract][Full Text] [Related]
19. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice. Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335 [TBL] [Abstract][Full Text] [Related]
20. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications. Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]